Dr. John Kellum, Chief Medical Officer of Spectral, stated, “We view December as a transitional month from an enrollment perspective, as the medical supply chain issues eased. Given the continued ...

In July 2022, the U.S. FDA granted Breakthrough Device Designation for PMX for the treatment of endotoxic septic shock. Approximately 330,000 patients are diagnosed with septic shock in North America ...